A novel splicing variant in ABCA1 in the first reported Hong Kong Chinese patient with high-density lipoprotein deficiency.

Autor:	Wong CL; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Hong Kong., Hung LY; Department of Pathology, Princess Margaret Hospital, Laichikok, Hong Kong., Siu WKC; Department of Pathology, Princess Margaret Hospital, Laichikok, Hong Kong., Tam VHK; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Hong Kong., Mak CM; Department of Pathology, Princess Margaret Hospital, Laichikok, Hong Kong.
Jazyk:	angličtina
Zdroj:	Endocrinology, diabetes & metabolism case reports [Endocrinol Diabetes Metab Case Rep] 2024 Aug 02; Vol. 2024 (3). Date of Electronic Publication: 2024 Aug 02 (Print Publication: 2024).
DOI:	10.1530/EDM-23-0102
Abstrakt:	Summary: Low high-density lipoprotein cholesterol (HDL-C) is a risk factor for cardiovascular disease. Very low HDL-C levels (less than 20 mg/dL), however, were uncommonly seen and can be due to genetic defects involving the metabolic pathway of high-density lipoprotein (HDL). We encountered a 50-year-old Chinese man who was only noticed to have extremely low HDL-C levels after surviving recurrent episodes of myocardial infarction. Further workup revealed the undetectable level of apolipoprotein A-I, the absence of HDL on gel electrophoresis, and a novel heterozygous splicing variant in the ABCA1 gene, which was predicted to be pathogenic by in silico analysis. To the best of our knowledge, this is the first reported Hong Kong Chinese with ABCA1 deficiency and probable Tangier disease. The association of ABCA1 deficiency/Tangier disease and accelerated atherosclerosis is discussed. Learning Points: Clinicians should be aware of the differential diagnoses of very low HDL-C, which could be divided into genetic and acquired causes. Genetic low HDL syndromes include apoA-I deficiency, Tangier disease, and familial LCAT deficiency, each of which has characteristic clinical features and can be differentiated from the other further by apoA-I measurement, lipoprotein analysis, and genetic testing. Patients with ABCA1 deficiency and Tangier disease are at risk of premature coronary artery disease and should be aggressively screened and treated for cardiovascular risk factors and established cardiovascular diseases. Revascularization strategy and indications for coronary artery bypass grafting in patients with Tangier disease and coronary artery disease follow that as for patients without Tangier disease.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu